Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$16.03 0.03 (0.19%)
2/9/2010 4:00 PM

Hologic, Inc. (HOLX)

CAPS Rating:
*****

The Company is a developer, manufacturer and supplier of diagnostic and medical imaging systems primarily dedicated to serving the healthcare needs of women.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating HOLX

Add Stock to Watchlist

What the Community Thinks

Total Members

714 Outperforms
22 Underperforms
 

All-Stars

220 Outperforms
4 Underperforms
 

Wall Street

14 Outperforms
2 Underperforms
 

Members bullish on HOLX are also bullish on:

Members bearish on HOLX are also bearish on:

Ticker Tags

Defensive (1457), Mid Cap (610), Healthcare (711), Healthcare Equipment and Supplies (176), Equipment (52)
Suggest a tag

Hologic, Inc. At A Glance

Current Price: $16.03
Last Trade Time: 2/9/2010 4:00 PM
Open: $0.00
Previous Close: $16.00
Daily Range: $15.98 - $16.36
52-Week Range: $9.31 - $17.83
Volume: 2,934,312
Market Cap: $4.14B
P/E Ratio: 55.89
Compare Our Special Broker Offers!

Stock Trends

HOLX VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

3

Hologic, Inc. (HOLX)

Avatar wolfhounds (22.99) Submitted: 5/05/09 10:39 AM

Stock is down 22% today, giving an excellent entry point. This is an over reaction to a quarterly report in which earnings beat again, and the company delivered $103m FCF despite a strong dollar and weak hospital environment. Overlooked is the continued growth in disposables, high margins, approval ...More

Replies: 2 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 104 :   1 2 3 4 5 Next » Jump to page:

Show Pitch Replies

Recs

0

 (HOLX)

Avatar MichaelKnows (74.84) Submitted: 1/08/10 11:57 PM : Outperform Start Price: $14.94 HOLX Score: 14.13

Hologic, the leader in womens healthcare in over nine sectors.. John Cumming was possibly the greatest CEO in womens healthcare and maybe the most successful as well.. Future acquisitions, global expansion, and Tomo approval will help company grow.. I don't see the company continuing like this forever. Rob C. the new Ceo doesnt have the same vision.

Report this Post Replies: 1 | Reply | Permalink

Recs

0

 (HOLX)

Avatar cashsage (32.22) Submitted: 12/11/09 12:27 PM : Underperform Start Price: $14.31 HOLX Score: -15.35

HOLX has a too high valuation compared to its sales potential. It is also one of the most loss making companies.

Report this Post Replies: 2 | Reply | Permalink

Recs

0

 (HOLX)

Avatar kevinottofro (99.35) Submitted: 11/15/09 7:01 PM : Outperform Start Price: $15.64 HOLX Score: 5.36

low relative PE, good star & 2010 earnings. Bottom fishing week of 11/9

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (HOLX)

Avatar stockworldpicks (88.61) Submitted: 9/17/09 3:37 PM : Outperform Start Price: $16.99 HOLX Score: -6.14

Hopping on with takover rumors should push the stock to at least $25

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (HOLX)

Avatar kcanant (99.65) Submitted: 6/27/09 6:06 AM : Outperform Start Price: $23.72 HOLX Score: -13.91

Digital breast radiography and women's health. A company with a lot of debt, serial acquirer. Overpaid for cytec. This is not a company that fits into my real$ portfolio, but I'm willing to hold it for CAPS. If it ever turns positive for me on CAPS, I will sell as soon as I notice it. Props to KitKat for write-up. http://boards.fool.com/Message.asp?mid=27670964

Report this Post Replies: 1 | Reply | Permalink

Results 1 - 5 of 104 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 16 of 16  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackBreanMurray 86.47 02/02/10 Outperform NS $16.16-0.80%-1.87%+1.06
TrackWellsFargo 80.02 11/25/09 Outperform NS $14.70+9.05%-3.55%+12.60
TrackStifel 96.44 08/28/09 Outperform NS $16.35-1.96%+4.48%-6.44
TrackSoleil 93.91 05/05/09 Underperform NS $12.11+32.37%+19.64%-12.73
TrackJimCramer < 20 04/23/09 Underperform 3W $13.80+16.16%+26.90%+10.74
TrackStandpoint 97.82 04/21/09 Outperform NS $14.12+13.53%+30.06%-16.53
TrackPiperJaff 85.79 04/14/09 Outperform NS $13.97+14.75%+26.93%-12.19
TrackMuhlenkamp 24.42 02/18/09 Outperform 5Y $13.56+18.22%+36.75%-18.53 Toggle the visibility of 60-Second Pitch and replies
TrackJefferies 82.08 01/12/09 Outperform NS $12.10+32.48%+22.82%+9.66
TrackLazardCapit < 20 09/04/08 Outperform NS $19.48-17.71%-11.46%-6.25
TrackEveillard 93.31 12/31/07 Outperform NS $34.32-53.29%-23.57%-29.72 Toggle the visibility of 60-Second Pitch and replies
TrackLehmanBros 85.06 10/17/07 Outperform NS $34.17-53.08%-27.52%-25.56
TrackBofASec 94.61 05/21/07 Outperform NS $27.50-41.71%-25.71%-16.00
TrackWRHambrecht 64.18 11/22/06 Outperform NS $24.14-33.58%-19.20%-14.38
TrackLeerinkSwan 92.83 11/22/06 Outperform NS $24.14-33.58%-19.20%-14.38

Results 1 - 16 of 16  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD01 796ms